SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Arzu Didem Yalcin, An Overview of the Effects of anti-IgE Therapies, Medical Science Monitor, 2014, 20, 1691

    CrossRef

  2. 2
    B. Sido, F.L. Dumoulin, J. Homann, H.-J. Hertfelder, M. Bollmann, G.J. Molderings, Chirurgische Eingriffe an Patienten mit Mastzellüberaktivitätserkrankung, Der Chirurg, 2014, 85, 4, 327

    CrossRef

  3. 3
    Britta Haenisch, Holger Fröhlich, Stefan Herms, Gerhard J. Molderings, Evidence for contribution of epigenetic mechanisms in the pathogenesis of systemic mast cell activation disease, Immunogenetics, 2014, 66, 5, 287

    CrossRef

  4. 4
    Vito Sabato, Els Van De Vijver, Margo Hagendorens, Inge Vrelust, Edwin Reyniers, Erik Fransen, Chris Bridts, Luc De Clerck, Geert Mortier, Peter Valent, Didier Ebo, Familial hypertryptasemia with associated mast cell activation syndrome, Journal of Allergy and Clinical Immunology, 2014, 134, 6, 1448

    CrossRef

  5. 5
    Lawrence B. Afrin, Mast Cell Activation Syndrome as a Significant Comorbidity in Sickle Cell Disease, The American Journal of the Medical Sciences, 2014, 348, 6, 460

    CrossRef

  6. 6
    Gerhard J. Molderings, The genetic basis of mast cell activation disease - looking through a glass darkly, Critical Reviews in Oncology/Hematology, 2014,

    CrossRef

  7. 7
    B. Haenisch, S. Herms, G. J. Molderings, The transcriptome of the human mast cell leukemia cells HMC-1.2: an approach to identify specific changes in the gene expression profile in KitD816V systemic mastocytosis, Immunologic Research, 2013, 56, 1, 155

    CrossRef

  8. 8
    Lawrence B Afrin, Utility of hydroxyurea in mast cell activation syndrome, Experimental Hematology & Oncology, 2013, 2, 1, 28

    CrossRef

  9. 9
    Jean-Yves Blay, Armelle Dufresne, Olfa Derbel, Isabelle Ray-Coquard, Targeted Therapies in Oncology, Second Edition, 2013,

    CrossRef